These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19933848)

  • 1. Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
    Adon AM; Zeng X; Harrison MK; Sannem S; Kiyokawa H; Kaldis P; Saavedra HI
    Mol Cell Biol; 2010 Feb; 30(3):694-710. PubMed ID: 19933848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
    Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
    Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication.
    Tarapore P; Okuda M; Fukasawa K
    Cell Cycle; 2002 Jan; 1(1):75-81. PubMed ID: 12429912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication.
    Duensing A; Liu Y; Tseng M; Malumbres M; Barbacid M; Duensing S
    Oncogene; 2006 May; 25(20):2943-9. PubMed ID: 16331279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts.
    Zhang X; Hagen J; Muniz VP; Smith T; Coombs GS; Eischen CM; Mackie DI; Roman DL; Van Rheeden R; Darbro B; Tompkins VS; Quelle DE
    PLoS One; 2013; 8(11):e80228. PubMed ID: 24282525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lats1 suppresses centrosome overduplication by modulating the stability of Cdc25B.
    Mukai S; Yabuta N; Yoshida K; Okamoto A; Miura D; Furuta Y; Abe T; Nojima H
    Sci Rep; 2015 Nov; 5():16173. PubMed ID: 26530630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
    Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
    Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication.
    Ma Z; Kanai M; Kawamura K; Kaibuchi K; Ye K; Fukasawa K
    Mol Cell Biol; 2006 Dec; 26(23):9016-34. PubMed ID: 17015463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.
    Tokuyama Y; Horn HF; Kawamura K; Tarapore P; Fukasawa K
    J Biol Chem; 2001 Jun; 276(24):21529-37. PubMed ID: 11278991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
    Hanashiro K; Brancaccio M; Fukasawa K
    Oncogene; 2011 May; 30(19):2188-97. PubMed ID: 21242972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway.
    Tarapore P; Horn HF; Tokuyama Y; Fukasawa K
    Oncogene; 2001 May; 20(25):3173-84. PubMed ID: 11423967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
    Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
    Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability.
    Cheng X; Shen Z; Yang J; Lu SH; Cui Y
    J Biol Chem; 2008 Feb; 283(9):5888-98. PubMed ID: 18162463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
    Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
    Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells.
    Hanashiro K; Kanai M; Geng Y; Sicinski P; Fukasawa K
    Oncogene; 2008 Sep; 27(40):5288-302. PubMed ID: 18490919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nucleophosmin in centrosome duplication.
    Okuda M
    Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
    Okuda M; Horn HF; Tarapore P; Tokuyama Y; Smulian AG; Chan PK; Knudsen ES; Hofmann IA; Snyder JD; Bove KE; Fukasawa K
    Cell; 2000 Sep; 103(1):127-40. PubMed ID: 11051553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
    Shinmura K; Bennett RA; Tarapore P; Fukasawa K
    Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
    Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
    Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.